Role of parkin mutations in 111 community-based patients with early-onset parkinsonism

被引:105
作者
Kann, M
Jacobs, H
Mohrmann, K
Schumacher, K
Hedrich, K
Garrels, J
Wiegers, K
Schwinger, E
Pramstaller, PP
Breakefield, XO
Ozelius, LJ
Vieregge, P
Klein, C
机构
[1] Med Univ Lubeck, Neurol Klin, Dept Neurol, D-23538 Lubeck, Germany
[2] Med Univ Lubeck, Dept Human Genet, D-23538 Lubeck, Germany
[3] Hosp Rothenburg Wumme, Dept Neurol, Rothenburg, Germany
[4] Gen Reg Hosp Bolzano, Dept Neurol, Bolzano, Italy
[5] Massachusetts Gen Hosp, Dept Neurol, Mol Neurogenet Unit, Boston, MA 02114 USA
[6] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA
[7] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA
[8] Lippe Lemgo Hosp, Lemgo, Germany
关键词
D O I
10.1002/ana.10179
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Early-onset parkinsonism is frequently reported in connection with mutations in the parkin gene. In this study, we present the results of extensive genetic screening for parkin mutations in 111 community-derived early-onset parkinsonism patients (age of onset <50 years) from Germany with an overall mutation rate of 9.0%. Gene dosage alterations represented 67% of the mutations found, underlining the importance of quantitative analyses of parkin. In summary, parkin mutations accounted for a low but significant percentage of early-onset parkinsonism patients in a community-derived sample.
引用
收藏
页码:621 / 625
页数:5
相关论文
共 21 条
[1]   A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe [J].
Abbas, N ;
Lücking, CB ;
Ricard, S ;
Dürr, A ;
Bonifati, V ;
De Michele, G ;
Bouley, S ;
Vaughan, JR ;
Gasser, T ;
Marconi, R ;
Broussolle, E ;
Brefel-Courbon, C ;
Harhangi, BS ;
Oostra, AB ;
Fabrizio, E ;
Böhme, GA ;
Pradier, L ;
Wood, NW ;
Filla, A ;
Meco, G ;
Denefle, P ;
Agid, Y ;
Brice, A .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :567-574
[2]   Dopa-responsive dystonia: A clinical and molecular genetic study [J].
Bandmann, O ;
Valente, EM ;
Holmans, P ;
Surtees, RAH ;
Walters, JH ;
Wevers, RA ;
Marsden, CD ;
Wood, NW .
ANNALS OF NEUROLOGY, 1998, 44 (04) :649-656
[3]   THE RELEVANCE OF THE LEWY BODY TO THE PATHOGENESIS OF IDIOPATHIC PARKINSONS-DISEASE [J].
GIBB, WRG ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (06) :745-752
[4]   Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism:: Evidence for variable homozygous deletions in the Parkin gene in affected individuals [J].
Hattori, N ;
Kitada, T ;
Matsumine, H ;
Asakawa, S ;
Yamamura, Y ;
Yoshino, H ;
Kobayashi, T ;
Yokochi, M ;
Wang, M ;
Yoritaka, A ;
Kondo, T ;
Kuzuhara, S ;
Nakamura, S ;
Shimizu, N ;
Mizuno, Y .
ANNALS OF NEUROLOGY, 1998, 44 (06) :935-941
[5]   The importance of gene dosage studies:: mutational analysis of the parkin gene in early-onset parkinsonism [J].
Hedrich, K ;
Kann, M ;
Lanthaler, AJ ;
Dalski, A ;
Eskelson, C ;
Landt, F ;
Schwinger, E ;
Vieregge, P ;
Lang, AE ;
Breakefield, XO ;
Ozelius, LJ ;
Pramstaller, PP ;
Klein, C .
HUMAN MOLECULAR GENETICS, 2001, 10 (16) :1649-1656
[6]   Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity [J].
Imai, Y ;
Soda, M ;
Takahashi, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) :35661-35664
[7]   An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin [J].
Imai, Y ;
Soda, M ;
Inoue, H ;
Hattori, N ;
Mizuno, Y ;
Takahashi, R .
CELL, 2001, 105 (07) :891-902
[8]   Personality traits in young patients with Parkinson's disease [J].
Jacobs, H ;
Heberlein, I ;
Vieregge, A ;
Vieregge, P .
ACTA NEUROLOGICA SCANDINAVICA, 2001, 103 (02) :82-87
[9]   Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [J].
Kitada, T ;
Asakawa, S ;
Hattori, N ;
Matsumine, H ;
Yamamura, Y ;
Minoshima, S ;
Yokochi, M ;
Mizuno, Y ;
Shimizu, N .
NATURE, 1998, 392 (6676) :605-608
[10]  
Klein C, 2000, ANN NEUROL, V48, P65, DOI 10.1002/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO